TMA leads the way at GCOM 2024

TMA recently returned from a high-profile week in Pittsburgh, Pennsylvania at the Global Conference on Myositis (GCOM)! Along with the almost 400 attendees for the scientific program, TMA helped lead…

Continue Reading

Tackling a good cause

TMA is grateful to Chelsi Boiardi and the New England Patriots for choosing our organization as the beneficiary of their My Cause My Cleats campaign.

Continue Reading

Vamorolone approved by FDA

Recently, the FDA announced the approval of a new drug, vamorolone, as a treatment for Duchenne muscular dystrophy (DMD), a genetic muscle disease that usually affects young boys. Understandably, this…

Continue Reading

IBM patients battle for veterans benefits

Recently, two members of TMA’s Military Veterans with Myositis Affinity Group were successful in acquiring disability benefits from the Veterans Administration. These benefits are significant. Not only are these former…

Continue Reading